查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2041757

藥物釋放型球囊導管市場預測至 2034 年—按產品、藥物、材料、最終用戶和地區進行全球分析。

Drug-eluting Balloon Catheters Market Forecasts to 2034 - Global Analysis By Product (Coronary Artery Balloon Catheters and Peripheral Vascular Balloon Catheters), Drug, Material, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，預計到 2026 年，全球藥物釋放型球囊導管市場規模將達到 8.879 億美元，並在預測期內以 10.9% 的複合年成長率成長，到 2034 年將達到 20.315 億美元。

醫療設備藥物釋放型球囊導管（DEB）是一種用於治療周邊動脈疾病（PAD）和冠狀動脈疾病（CAD）的心臟介入器械。這些導管的作用是將藥物直接輸送到受損血管壁，以防止血管血管再阻塞術後再狹窄。由於藥物塗層和導管技術的進步，以及旨在改善患者療效和安全性的持續臨床研究，藥物釋放型球囊導管市場正在不斷發展。

根據美國心臟協會 (AHA) 2021 年的報告，周邊動脈疾病(PAD) 影響著全球超過 2 億人，且與高死亡率和高發病率有關。此外，易患心血管疾病的老年人口不斷增加以及醫療保健成本的上升預計將推動市場成長。

心血管疾病盛行率

隨著心血管疾病發生率的上升，需要介入治療以控制動脈阻塞的患者數量也在增加。對於這些患者而言，藥物釋放型球囊導管可能是一種有效的治療選擇，這可能會導致使用該器械的手術數量增加。此外，心血管疾病帶來的經濟負擔，包括追蹤護理、住院和治療費用，都會影響醫療成本。因此，藥物釋放型球囊導管是一種創新且成功的治療方法方法，如果能夠證明其可以透過減少血管再阻塞和再次治療來降低長期醫療保健成本，則有望得到更廣泛的應用，而這將成為推動市場成長的主要因素。

缺乏某些類型病變的臨床證據

當支持使用藥物釋放型球囊導管的臨床數據有限時，醫療專業人員針對特定病變類型的有效治療選擇可能會減少。這種限制可能導致某些動脈病變患者無法獲得最佳治療。當這些裝置被視為有前景的替代方案，但缺乏可靠的數據來支持其應用時，這種趨勢尤其明顯。雖然此類系統在某些情況下可能是有益的，但醫療專業人員可能會選擇更成熟、循證的治療方法。因此，改善患者照護和推動市場成長的機會可能會錯失。

臨床證據的擴展

藥物釋放型球囊導管安全有效，並已證實具有良好的長期療效。這些數據支持其應用，並鼓勵醫療專業人員採用。隨著越來越多的臨床數據證實藥物釋放型球囊導管的益處，有望對醫療保險機構的報銷決策產生正面影響。進一步證實患者療效改善的證據將有助於制定更優惠的報銷規則，從而擴大市場准入並提高器械使用率。

成本考量與還款挑戰

患者獲得藥物釋放型球囊導管的機會可能受到支付問題的阻礙，尤其是在保險覆蓋範圍和報銷政策不完善的地區和醫療體系中。這種限制可能導致患者無法平等地獲得前沿治療方法，並可能根據保險覆蓋範圍和所在地區影響預後。報銷困難和保險核准延遲可能會阻礙藥物釋放型球囊導管的市場滲透和接受度。

新冠疫情的感染疾病

在尖峰時段，許多醫院和醫療機構優先救治新冠肺炎患者，因此，包括藥物釋放型球囊血管成形術等非緊急心臟介入手術在內的擇期手術被推遲或取消。由此導致市場上此類器械的需求量下降。隨著疫苗接種率的提高和醫療系統對疫情傳播的適應，擇期手術和非緊急介入手術逐漸恢復。隨著許多醫療機構恢復運營，對心血管治療的需求，特別是需要使用藥物洗脫球囊導管的治療需求，也隨之增加。

在預測期內，冠狀動脈球囊導管部分預計將是最大的部分。

冠狀動脈球囊導管領域預計將實現盈利成長，因為該領域包含用於清除或擴張冠狀動脈阻塞、恢復心肌供血的裝置。特別是藥物釋放型球囊導管，它能將藥物直接輸送到動脈阻塞部位，進而預防血管再阻塞。此外，這些裝置的應用日益廣泛，推動了市場成長，其促進因素包括：微創手術需求的不斷成長、心血管疾病盛行率的上升，以及藥物釋放型球囊導管比傳統血管成形術更能有效降低血管再阻塞率。

在預測期內，紫杉醇細分市場預計將呈現最高的複合年成長率。

預計在預測期內，紫杉醇細分市場將呈現最高的複合年成長率。這是因為紫杉醇在藥物釋放型球囊（DEB）導管中的應用引起了廣泛的關注和安全性研究，尤其令人擔憂的是其潛在的長期影響以及與周邊動脈疾病（PAD）患者死亡率增加的關聯。此外，由於圍繞這些器械的安全性問題，藥物釋放型球囊導管和其他紫杉醇塗層產品的市場動態正在改變。這導致了監測力度的加強、臨床操作流程的改變，以及關於病患選擇和長期安全性監測的討論。

市佔率最大的地區：

預計北美在預測期內將佔據最大的市場佔有率。這是因為北美擁有多家大型製造商，引進了技術先進的新設備，並且享有優惠的報銷政策，這些都是影響其市場佔有率的關鍵因素。例如，根據美國心臟協會估計，美國每年進行超過50萬例經皮冠狀動脈介入治療（包括經皮冠狀動脈介入術）。

複合年成長率最高的地區：

由於醫療保健成本不斷上漲以及心血管疾病高發，預計亞太地區在預測期內將呈現最高的複合年成長率。根據Biomedcentral通報，約有五分之一的中國人患有心血管疾病。此外，中國和日本等國家可支配收入的成長和人口老化預計將推動該地區的需求。開發中國家醫療旅遊的成長也促進了該產業的發展。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域細分
    • 應客戶要求，我們提供主要國家的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

目錄

第1章執行摘要

第2章：引言

  • 概括
  • 相關利益者
  • 調查範圍
  • 調查方法
  • 研究材料

第3章 市場趨勢分析

  • 促進因素
  • 抑制因子
  • 機會
  • 威脅
  • 產品分析
  • 最終用戶分析
  • 新興市場
  • 新冠疫情的感染疾病

第4章：波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的競爭

第5章 全球藥物釋放型球囊導管市場：依產品分類

  • 冠狀動脈球囊導管
  • 周邊血管球囊導管

第6章 全球藥物釋放型球囊導管市場：依藥物類型分類

  • Sirolimus
  • 紫杉醇
  • 其他藥物

第7章 全球藥物釋放型球囊導管市場：依材料分類

  • 尼龍
  • 聚氨酯
  • 其他材料

第8章 全球藥物釋放型球囊導管市場：依最終用戶分類

  • 門診手術中心
  • 導管檢查室
  • 醫院和診所
  • 其他最終用戶

第9章 全球藥物釋放型球囊導管市場：依地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太國家
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • UAE
    • 卡達
    • 南非
    • 其他中東和非洲國家

第10章 主要發展

  • 合約、夥伴關係、合作關係、合資企業
  • 收購與併購
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第11章：公司簡介

  • Aachen Resonance GmbH
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Biotronik AG
  • iVascular SLU
  • Lepu Medical Technology（Beijing）Co. Ltd.
  • MedAlliance
  • Medtronic plc
  • Biosensors International
  • Eurocor GmbH
  • Zhejiang Barty Medical Technology Co.Ltd
  • Cook Group Incorporated
  • Terumo Corporation
  • SurModics Inc
  • Koninklijke Philips NV
  • Jotech GmbH
  • MicroPort Scientific Corporation
  • Cordis Corporation
  • Cardionovum GmbH
  • Abbott Laboratories
Product Code: SMRC24821

According to Stratistics MRC, the Global Drug-eluting Balloon Catheters Market is accounted for $887.9 million in 2026 and is expected to reach $2031.5 million by 2034 growing at a CAGR of 10.9% during the forecast period. Medical devices called drug-eluting balloon catheters (DEBs) are used in interventional cardiology to treat peripheral arterial disease (PAD) and coronary artery disease (CAD). The purpose of these catheters is to administer medication straight to the damaged blood vessel walls in order to stop restenosis, or the constriction of blood vessels after angioplasty treatments. With developments in drug coatings, catheter technology, and continuing clinical research focused on improving patient outcomes and safety, the market for drug-eluting balloon catheters is continually changing.

According to the American Heart Association 2021 report, peripheral artery disease (PAD) affects more than 200 million people worldwide and is associated with high mortality and morbidity. Moreover, the increasing geriatric population, which is prone to cardiovascular diseases and growing healthcare spending are projected to bolster market growth

Market Dynamics:

Driver:

Prevalence of cardiovascular diseases

The number of individuals in need of interventional therapies to control arterial blockages grows in tandem with the frequency of cardiovascular disorders. For these patients, drug-eluting balloon catheters provide an efficient therapeutic alternative that may result in an increase in the number of procedures using these devices. Additionally, healthcare cost is influenced by the financial burden of cardiovascular illnesses, which includes follow-up care, hospital stays, and therapies. Thus drug-eluting balloon catheters are one example of an innovative and successful treatment that may be more widely used if it can be demonstrated to save long-term healthcare expenditures by reducing restenosis and recurring procedures which encourage the growth of the market.

Restraint:

Limited clinical evidence in some lesion types

There may be fewer effective treatment choices available to healthcare practitioners for particular lesion types if there is limited clinical data supporting the use of drug-eluting balloon catheters. This restriction may result in patients with certain arterial lesions not receiving the best care possible, especially if these are thought to be a potentially good alternative but have no solid data to support their use. Even while these systems could be beneficial in some circumstances, they might choose more well-established therapies with more evidence, missing out on chances to improve patient care thereby propel the growth of the market.

Opportunity:

Expanding clinical evidence

Drug-eluting balloon catheters are safe, effective, and have good long-term results; this data supports their use and encourages healthcare practitioners to use them. Increased clinical data demonstrating the advantages of drug-eluting balloon catheters can have a favourable impact on healthcare payers' judgments about reimbursement. More proof of better patient outcomes might support reimbursement rules that are more favourable, increasing market access and device usage.

Threat:

Cost considerations and reimbursement challenges

Patients' access to drug-eluting balloon catheters may be hampered by payment issues, especially in areas or healthcare systems with unfavourable coverage or reimbursement laws. Due to this restriction, patients may not have equal access to cutting-edge therapies, which might have an effect on their prognosis depending on their insurance status or region. Difficulties with reimbursement or hold-ups in receiving positive coverage decisions might hinder drug-eluting balloon catheters market penetration and acceptance.

Covid-19 Impact

Many hospitals and healthcare facilities gave priority to COVID-19 patients when it came to resources during the pandemic's height. Elective operations, including non-urgent cardiac interventions like drug-eluting balloon angioplasty, had to be postponed or cancelled as a result. As a result, the number of procedures performed on the market for these devices decreased. Elective operations and non-urgent interventions showed a steady recovery as vaccination rates rose and healthcare systems adjusted to the epidemic. As a result of several healthcare institutions starting up again, there was an increase in demand for cardiovascular treatments, especially those requiring balloon catheters that release medication.

The coronary artery balloon catheters segment is expected to be the largest during the forecast period

The coronary artery balloon catheters segment is estimated to have a lucrative growth, as these gadgets are intended to unblock or widen coronary arteries in order to replenish blood supply to the heart muscle. In particular, drug-eluting balloon catheters are a kind of catheter that, in order to avoid restenosis, provide medication right to the location of an arterial blockage. Moreover these are becoming more and more popular; as these devices are driven by factors like the need for less invasive procedures, the prevalence of cardiovascular diseases rising, and the fact that drug-eluting balloons reduce restenosis rates more effectively than traditional angioplasty which drives the growth of the market.

The paclitaxel segment is expected to have the highest CAGR during the forecast period

The paclitaxel segment is anticipated to witness the highest CAGR growth during the forecast period, because its usage in drug-eluting balloon (DEB) catheters has drawn a lot of attention and investigation because of worries about its safety, especially in light of possible long-term consequences and a link to higher death rates in patients with peripheral artery disease (PAD). Furthermore, drug-eluting balloon catheters and other paclitaxel-coated goods have seen changes in their market dynamics due to safety concerns surrounding these devices. Thus increased scrutiny, modifications to clinical procedures and conversations about patient selection and long-term safety monitoring have resulted from it.

Region with largest share:

North America is projected to hold the largest market share during the forecast period owing to the availability of several large manufacturers, the introduction of new, technologically sophisticated equipment, and advantageous reimbursement policies are all key contributors to the market share that is seen in North America. For instance, according to estimates from the American Heart Association, more than 500,000 percutaneous coronary procedures including percutaneous transluminal coronary interventions are performed in the United States each year.

Region with highest CAGR:

Asia Pacific is projected to have the highest CAGR over the forecast period, owing to both the rise in healthcare costs and the prevalence of cardiovascular diseases. According to Biomedcentral, almost one in five Chinese people suffer from cardiovascular disease. Furthermore, it is projected that growing disposable income and an older population in nations like China and Japan would fuel demand in the area. The growth of health tourism in developing nations is also contributing to the industry's progress in this sector.

Key players in the market

Some of the key players profiled in the Drug-eluting Balloon Catheters Market include Aachen Resonance GmbH, B. Braun Melsungen AG, Becton, Dickinson and Company, Biotronik AG, iVascular S.L.U., Lepu Medical Technology (Beijing) Co. Ltd., MedAlliance, Medtronic plc, Biosensors International, Eurocor GmbH, Zhejiang Barty Medical Technology Co.Ltd, Cook Group Incorporated, Terumo Corporation, SurModics Inc, Koninklijke Philips NV, Jotech GmbH, MicroPort Scientific Corporation, Cordis Corporation, Cardionovum GmbH and Abbott Laboratories

Key Developments:

In November 2023, BD launched a new, advanced ultrasound system designed to help improve clinician efficiency when placing peripherally inserted central catheters (PICCs), central venous catheters, IV lines and other vascular access devices.

In October 2023, Philips OneBlade Partners with College Rivals for an Epic Gaming Journey Enabling Gen Z to 'Move Fearlessly' this is the third strategic partnership in a year that aims to strengthen the brand's commitment to reaching the GenZ audience.

In August 2023, Philips expands local manufacturing of Personal Health products in India to serve local demand, in addition to the beauty and grooming products already being made at the site.

Products Covered:

  • Coronary Artery Balloon Catheters
  • Peripheral Vascular Balloon Catheters

Drugs Covered:

  • Sirolimus
  • Paclitaxel
  • Other Drugs

Materials Covered:

  • Nylon
  • Polyurethane
  • Other Materials

End Users Covered:

  • Ambulatory Surgical Centers
  • Catheterization Laboratories
  • Hospitals & clinics
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Drug-eluting Balloon Catheters Market, By Product

  • 5.1 Introduction
  • 5.2 Coronary Artery Balloon Catheters
  • 5.3 Peripheral Vascular Balloon Catheters

6 Global Drug-eluting Balloon Catheters Market, By Drug

  • 6.1 Introduction
  • 6.2 Sirolimus
  • 6.3 Paclitaxel
  • 6.4 Other Drugs

7 Global Drug-eluting Balloon Catheters Market, By Material

  • 7.1 Introduction
  • 7.2 Nylon
  • 7.3 Polyurethane
  • 7.4 Other Materials

8 Global Drug-eluting Balloon Catheters Market, By End User

  • 8.1 Introduction
  • 8.2 Ambulatory Surgical Centers
  • 8.3 Catheterization Laboratories
  • 8.4 Hospitals & clinics
  • 8.5 Other End Users

9 Global Drug-eluting Balloon Catheters Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Aachen Resonance GmbH
  • 11.2 B. Braun Melsungen AG
  • 11.3 Becton, Dickinson and Company
  • 11.4 Biotronik AG
  • 11.5 iVascular S.L.U.
  • 11.6 Lepu Medical Technology(Beijing) Co. Ltd.
  • 11.7 MedAlliance
  • 11.8 Medtronic plc
  • 11.9 Biosensors International
  • 11.10 Eurocor GmbH
  • 11.11 Zhejiang Barty Medical Technology Co.Ltd
  • 11.12 Cook Group Incorporated
  • 11.13 Terumo Corporation
  • 11.14 SurModics Inc
  • 11.15 Koninklijke Philips NV
  • 11.16 Jotech GmbH
  • 11.17 MicroPort Scientific Corporation
  • 11.18 Cordis Corporation
  • 11.19 Cardionovum GmbH
  • 11.20 Abbott Laboratories

List of Tables

  • Table 1 Global Drug-eluting Balloon Catheters Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Drug-eluting Balloon Catheters Market Outlook, By Product (2023-2034) ($MN)
  • Table 3 Global Drug-eluting Balloon Catheters Market Outlook, By Coronary Artery Balloon Catheters (2023-2034) ($MN)
  • Table 4 Global Drug-eluting Balloon Catheters Market Outlook, By Peripheral Vascular Balloon Catheters (2023-2034) ($MN)
  • Table 5 Global Drug-eluting Balloon Catheters Market Outlook, By Drug (2023-2034) ($MN)
  • Table 6 Global Drug-eluting Balloon Catheters Market Outlook, By Sirolimus (2023-2034) ($MN)
  • Table 7 Global Drug-eluting Balloon Catheters Market Outlook, By Paclitaxel (2023-2034) ($MN)
  • Table 8 Global Drug-eluting Balloon Catheters Market Outlook, By Other Drugs (2023-2034) ($MN)
  • Table 9 Global Drug-eluting Balloon Catheters Market Outlook, By Material (2023-2034) ($MN)
  • Table 10 Global Drug-eluting Balloon Catheters Market Outlook, By Nylon (2023-2034) ($MN)
  • Table 11 Global Drug-eluting Balloon Catheters Market Outlook, By Polyurethane (2023-2034) ($MN)
  • Table 12 Global Drug-eluting Balloon Catheters Market Outlook, By Other Materials (2023-2034) ($MN)
  • Table 13 Global Drug-eluting Balloon Catheters Market Outlook, By End User (2023-2034) ($MN)
  • Table 14 Global Drug-eluting Balloon Catheters Market Outlook, By Ambulatory Surgical Centers (2023-2034) ($MN)
  • Table 15 Global Drug-eluting Balloon Catheters Market Outlook, By Catheterization Laboratories (2023-2034) ($MN)
  • Table 16 Global Drug-eluting Balloon Catheters Market Outlook, By Hospitals & clinics (2023-2034) ($MN)
  • Table 17 Global Drug-eluting Balloon Catheters Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 18 North America Drug-eluting Balloon Catheters Market Outlook, By Country (2023-2034) ($MN)
  • Table 19 North America Drug-eluting Balloon Catheters Market Outlook, By Product (2023-2034) ($MN)
  • Table 20 North America Drug-eluting Balloon Catheters Market Outlook, By Coronary Artery Balloon Catheters (2023-2034) ($MN)
  • Table 21 North America Drug-eluting Balloon Catheters Market Outlook, By Peripheral Vascular Balloon Catheters (2023-2034) ($MN)
  • Table 22 North America Drug-eluting Balloon Catheters Market Outlook, By Drug (2023-2034) ($MN)
  • Table 23 North America Drug-eluting Balloon Catheters Market Outlook, By Sirolimus (2023-2034) ($MN)
  • Table 24 North America Drug-eluting Balloon Catheters Market Outlook, By Paclitaxel (2023-2034) ($MN)
  • Table 25 North America Drug-eluting Balloon Catheters Market Outlook, By Other Drugs (2023-2034) ($MN)
  • Table 26 North America Drug-eluting Balloon Catheters Market Outlook, By Material (2023-2034) ($MN)
  • Table 27 North America Drug-eluting Balloon Catheters Market Outlook, By Nylon (2023-2034) ($MN)
  • Table 28 North America Drug-eluting Balloon Catheters Market Outlook, By Polyurethane (2023-2034) ($MN)
  • Table 29 North America Drug-eluting Balloon Catheters Market Outlook, By Other Materials (2023-2034) ($MN)
  • Table 30 North America Drug-eluting Balloon Catheters Market Outlook, By End User (2023-2034) ($MN)
  • Table 31 North America Drug-eluting Balloon Catheters Market Outlook, By Ambulatory Surgical Centers (2023-2034) ($MN)
  • Table 32 North America Drug-eluting Balloon Catheters Market Outlook, By Catheterization Laboratories (2023-2034) ($MN)
  • Table 33 North America Drug-eluting Balloon Catheters Market Outlook, By Hospitals & clinics (2023-2034) ($MN)
  • Table 34 North America Drug-eluting Balloon Catheters Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 35 Europe Drug-eluting Balloon Catheters Market Outlook, By Country (2023-2034) ($MN)
  • Table 36 Europe Drug-eluting Balloon Catheters Market Outlook, By Product (2023-2034) ($MN)
  • Table 37 Europe Drug-eluting Balloon Catheters Market Outlook, By Coronary Artery Balloon Catheters (2023-2034) ($MN)
  • Table 38 Europe Drug-eluting Balloon Catheters Market Outlook, By Peripheral Vascular Balloon Catheters (2023-2034) ($MN)
  • Table 39 Europe Drug-eluting Balloon Catheters Market Outlook, By Drug (2023-2034) ($MN)
  • Table 40 Europe Drug-eluting Balloon Catheters Market Outlook, By Sirolimus (2023-2034) ($MN)
  • Table 41 Europe Drug-eluting Balloon Catheters Market Outlook, By Paclitaxel (2023-2034) ($MN)
  • Table 42 Europe Drug-eluting Balloon Catheters Market Outlook, By Other Drugs (2023-2034) ($MN)
  • Table 43 Europe Drug-eluting Balloon Catheters Market Outlook, By Material (2023-2034) ($MN)
  • Table 44 Europe Drug-eluting Balloon Catheters Market Outlook, By Nylon (2023-2034) ($MN)
  • Table 45 Europe Drug-eluting Balloon Catheters Market Outlook, By Polyurethane (2023-2034) ($MN)
  • Table 46 Europe Drug-eluting Balloon Catheters Market Outlook, By Other Materials (2023-2034) ($MN)
  • Table 47 Europe Drug-eluting Balloon Catheters Market Outlook, By End User (2023-2034) ($MN)
  • Table 48 Europe Drug-eluting Balloon Catheters Market Outlook, By Ambulatory Surgical Centers (2023-2034) ($MN)
  • Table 49 Europe Drug-eluting Balloon Catheters Market Outlook, By Catheterization Laboratories (2023-2034) ($MN)
  • Table 50 Europe Drug-eluting Balloon Catheters Market Outlook, By Hospitals & clinics (2023-2034) ($MN)
  • Table 51 Europe Drug-eluting Balloon Catheters Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 52 Asia Pacific Drug-eluting Balloon Catheters Market Outlook, By Country (2023-2034) ($MN)
  • Table 53 Asia Pacific Drug-eluting Balloon Catheters Market Outlook, By Product (2023-2034) ($MN)
  • Table 54 Asia Pacific Drug-eluting Balloon Catheters Market Outlook, By Coronary Artery Balloon Catheters (2023-2034) ($MN)
  • Table 55 Asia Pacific Drug-eluting Balloon Catheters Market Outlook, By Peripheral Vascular Balloon Catheters (2023-2034) ($MN)
  • Table 56 Asia Pacific Drug-eluting Balloon Catheters Market Outlook, By Drug (2023-2034) ($MN)
  • Table 57 Asia Pacific Drug-eluting Balloon Catheters Market Outlook, By Sirolimus (2023-2034) ($MN)
  • Table 58 Asia Pacific Drug-eluting Balloon Catheters Market Outlook, By Paclitaxel (2023-2034) ($MN)
  • Table 59 Asia Pacific Drug-eluting Balloon Catheters Market Outlook, By Other Drugs (2023-2034) ($MN)
  • Table 60 Asia Pacific Drug-eluting Balloon Catheters Market Outlook, By Material (2023-2034) ($MN)
  • Table 61 Asia Pacific Drug-eluting Balloon Catheters Market Outlook, By Nylon (2023-2034) ($MN)
  • Table 62 Asia Pacific Drug-eluting Balloon Catheters Market Outlook, By Polyurethane (2023-2034) ($MN)
  • Table 63 Asia Pacific Drug-eluting Balloon Catheters Market Outlook, By Other Materials (2023-2034) ($MN)
  • Table 64 Asia Pacific Drug-eluting Balloon Catheters Market Outlook, By End User (2023-2034) ($MN)
  • Table 65 Asia Pacific Drug-eluting Balloon Catheters Market Outlook, By Ambulatory Surgical Centers (2023-2034) ($MN)
  • Table 66 Asia Pacific Drug-eluting Balloon Catheters Market Outlook, By Catheterization Laboratories (2023-2034) ($MN)
  • Table 67 Asia Pacific Drug-eluting Balloon Catheters Market Outlook, By Hospitals & clinics (2023-2034) ($MN)
  • Table 68 Asia Pacific Drug-eluting Balloon Catheters Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 69 South America Drug-eluting Balloon Catheters Market Outlook, By Country (2023-2034) ($MN)
  • Table 70 South America Drug-eluting Balloon Catheters Market Outlook, By Product (2023-2034) ($MN)
  • Table 71 South America Drug-eluting Balloon Catheters Market Outlook, By Coronary Artery Balloon Catheters (2023-2034) ($MN)
  • Table 72 South America Drug-eluting Balloon Catheters Market Outlook, By Peripheral Vascular Balloon Catheters (2023-2034) ($MN)
  • Table 73 South America Drug-eluting Balloon Catheters Market Outlook, By Drug (2023-2034) ($MN)
  • Table 74 South America Drug-eluting Balloon Catheters Market Outlook, By Sirolimus (2023-2034) ($MN)
  • Table 75 South America Drug-eluting Balloon Catheters Market Outlook, By Paclitaxel (2023-2034) ($MN)
  • Table 76 South America Drug-eluting Balloon Catheters Market Outlook, By Other Drugs (2023-2034) ($MN)
  • Table 77 South America Drug-eluting Balloon Catheters Market Outlook, By Material (2023-2034) ($MN)
  • Table 78 South America Drug-eluting Balloon Catheters Market Outlook, By Nylon (2023-2034) ($MN)
  • Table 79 South America Drug-eluting Balloon Catheters Market Outlook, By Polyurethane (2023-2034) ($MN)
  • Table 80 South America Drug-eluting Balloon Catheters Market Outlook, By Other Materials (2023-2034) ($MN)
  • Table 81 South America Drug-eluting Balloon Catheters Market Outlook, By End User (2023-2034) ($MN)
  • Table 82 South America Drug-eluting Balloon Catheters Market Outlook, By Ambulatory Surgical Centers (2023-2034) ($MN)
  • Table 83 South America Drug-eluting Balloon Catheters Market Outlook, By Catheterization Laboratories (2023-2034) ($MN)
  • Table 84 South America Drug-eluting Balloon Catheters Market Outlook, By Hospitals & clinics (2023-2034) ($MN)
  • Table 85 South America Drug-eluting Balloon Catheters Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 86 Middle East & Africa Drug-eluting Balloon Catheters Market Outlook, By Country (2023-2034) ($MN)
  • Table 87 Middle East & Africa Drug-eluting Balloon Catheters Market Outlook, By Product (2023-2034) ($MN)
  • Table 88 Middle East & Africa Drug-eluting Balloon Catheters Market Outlook, By Coronary Artery Balloon Catheters (2023-2034) ($MN)
  • Table 89 Middle East & Africa Drug-eluting Balloon Catheters Market Outlook, By Peripheral Vascular Balloon Catheters (2023-2034) ($MN)
  • Table 90 Middle East & Africa Drug-eluting Balloon Catheters Market Outlook, By Drug (2023-2034) ($MN)
  • Table 91 Middle East & Africa Drug-eluting Balloon Catheters Market Outlook, By Sirolimus (2023-2034) ($MN)
  • Table 92 Middle East & Africa Drug-eluting Balloon Catheters Market Outlook, By Paclitaxel (2023-2034) ($MN)
  • Table 93 Middle East & Africa Drug-eluting Balloon Catheters Market Outlook, By Other Drugs (2023-2034) ($MN)
  • Table 94 Middle East & Africa Drug-eluting Balloon Catheters Market Outlook, By Material (2023-2034) ($MN)
  • Table 95 Middle East & Africa Drug-eluting Balloon Catheters Market Outlook, By Nylon (2023-2034) ($MN)
  • Table 96 Middle East & Africa Drug-eluting Balloon Catheters Market Outlook, By Polyurethane (2023-2034) ($MN)
  • Table 97 Middle East & Africa Drug-eluting Balloon Catheters Market Outlook, By Other Materials (2023-2034) ($MN)
  • Table 98 Middle East & Africa Drug-eluting Balloon Catheters Market Outlook, By End User (2023-2034) ($MN)
  • Table 99 Middle East & Africa Drug-eluting Balloon Catheters Market Outlook, By Ambulatory Surgical Centers (2023-2034) ($MN)
  • Table 100 Middle East & Africa Drug-eluting Balloon Catheters Market Outlook, By Catheterization Laboratories (2023-2034) ($MN)
  • Table 101 Middle East & Africa Drug-eluting Balloon Catheters Market Outlook, By Hospitals & clinics (2023-2034) ($MN)
  • Table 102 Middle East & Africa Drug-eluting Balloon Catheters Market Outlook, By Other End Users (2023-2034) ($MN)